SCHEMBL8307666

SCHEMBL8307666

CS(=O)(=O)c1ccc(CCC=O)cc1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 2/20 0.43
KCNJ1 P48048 1/20 0.43
KCNH2 Q12809 1/20 0.43
CA2 P00918 4/20 0.41
PTGS2 P35354 4/20 0.40
BMP1 P13497 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
AKR1C3 P42330 1/20 0.39
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA4 P22748 1/20 0.38
CA6 P23280 1/20 0.38
CA5A P35218 1/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38
CA14 Q9ULX7 1/20 0.38
CA5B Q9Y2D0 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13859132 0.82 PSIP1 (0.55) CA2SMN1; SMN2CA12CA1CA4
SCHEMBL21676191 0.82 KCNJ1 (0.39) ENPP2KCNJ1KCNH2CA2PTGS2
SCHEMBL1428902 0.81 ENPP2 (0.48) ENPP2KCNJ1KCNH2PTGS2AKR1C3
SCHEMBL9671868 0.80 HIF1A (0.37) CA2
SCHEMBL30663936 0.79 ALDH1A1 (0.38) CA2SMN1; SMN2CA12CA1CA4
SCHEMBL6793165 0.77 CA2 (0.67) ENPP2KCNJ1KCNH2CA2PTGS2
SCHEMBL2931021 0.76 ALDH1A1 (0.45) CA2SMN1; SMN2CA12CA1CA4
SCHEMBL1251844 0.75 CA2 (0.67) ENPP2KCNJ1KCNH2CA2SMN1; SMN2
SCHEMBL5535777 0.75 ENPP2 (0.46) ENPP2KCNJ1KCNH2CA2PTGS2
SCHEMBL6581495 0.75 ENPP2 (0.46) ENPP2KCNJ1KCNH2CA2PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102898357-A Novel process for the preparation of 1-(6-methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanone, an intermediate of etoricoxib. ITALIANA SINT SPA 2013-01-30 CN claimed
CN-119768164-A Pharmaceutical compounds for treating complement-mediated disorders 阿雷克森制药公司 2025-04-04 CN disclosed
CN-116332929-A 3-amido-beta-carboline compound, preparation method and application thereof 中国科学院上海药物研究所 2023-06-27 CN disclosed
EP-0904269-A1 3,4-DIARYL-2-HYDROXY-2,5-DIHYDROFURANS AS PRODRUGS TO COX-2 INHIBITORS MERCK FROSST CANADA INC. (CA) 1999-03-31 EP disclosed
EP-0863891-A1 (METHYLSULFONYL)PHENYL-2-(5H)-FURANONES AS COX-2 INHIBITORS MERCK FROSST CANADA INC. (CA) 1998-09-16 EP disclosed
WO-1997016435-A1 3,4-DIARYL-2-HYDROXY-2,5-DIHYDROFURANS AS PRODRUGS TO COX-2 INHIBITORS MERCK FROSST CANADA INC. (CA) 1997-05-09 WO disclosed
WO-1997014691-A1 (METHYLSULFONYL)PHENYL-2-(5H)-FURANONES AS COX-2 INHIBITORS MERCK FROSST CANADA INC. (CA) 1997-04-24 WO disclosed
US-4087549-A Sulphonic acid containing indenyl derivatives MERCK & CO., INC. (US) 1978-05-02 US disclosed